These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27486530)

  • 21. Oral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosis.
    Perumal JS; Caon C; Hreha S; Zabad R; Tselis A; Lisak R; Khan O
    Eur J Neurol; 2008 Jul; 15(7):677-80. PubMed ID: 18459972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose corticosteroid treatment is associated with an increased risk of developing cerebral venous thrombosis.
    Stolz E; Klötzsch C; Schlachetzki F; Rahimi A
    Eur Neurol; 2003; 49(4):247-8. PubMed ID: 12736545
    [No Abstract]   [Full Text] [Related]  

  • 23. Short-term combination of glatiramer acetate with i.v. steroid treatment preceding treatment with GA alone assessed by MRI-disease activity in patients with relapsing-remitting multiple sclerosis.
    De Stefano N; Filippi M; Hawkins C;
    J Neurol Sci; 2008 Mar; 266(1-2):44-50. PubMed ID: 17897678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurophysiological markers of relapse, remission and long-term recovery processes in MS.
    Jones SJ; Brusa A
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():584-90. PubMed ID: 10689512
    [No Abstract]   [Full Text] [Related]  

  • 25. Bradycardia after high-dose intravenous methylprednisolone therapy.
    Tvede N; Nielsen LP; Andersen V
    Scand J Rheumatol; 1986; 15(3):302-4. PubMed ID: 3798047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recurrent acute liver toxicity from intravenous methylprednisolone].
    Rivero Fernández M; Riesco JM; Moreira VF; Moreno A; López San Román A; Arranz G; Ruiz Del Arbol L
    Rev Esp Enferm Dig; 2008 Nov; 100(11):720-3. PubMed ID: 19159178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of infusion related reactions associated with alemtuzumab in patients with multiple sclerosis.
    Šega-Jazbec S; Barun B; Horvat Ledinek A; Fabekovac V; Krbot Skorić M; Habek M
    Mult Scler Relat Disord; 2017 Oct; 17():151-153. PubMed ID: 29055450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term effects of methylprednisolone on cerebral volume in multiple sclerosis relapses.
    Chapman C; Tubridy N; Cook MJ; Mitchell PJ; MacGregor LR; Lovelock C; Litewka L; Sedal L; Kilpatrick TJ; Butzkueven H
    J Clin Neurosci; 2006 Jul; 13(6):636-8. PubMed ID: 16790352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylprednisolone-induced acute liver injury in a patient treated for multiple sclerosis relapse.
    Bresteau C; Prevot S; Perlemuter G; Voican C
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29507031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.
    Sorensen PS; Mellgren SI; Svenningsson A; Elovaara I; Frederiksen JL; Beiske AG; Myhr KM; Søgaard LV; Olsen IC; Sandberg-Wollheim M
    Lancet Neurol; 2009 Jun; 8(6):519-29. PubMed ID: 19409854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newly onset sinus bradycardia in the context of multiple sclerosis relapse.
    Jurić S; Mišmaš A; Mihić N; Barać AM; Habek M
    Intern Med; 2012; 51(9):1121-4. PubMed ID: 22576400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mega dose intravenous methylprednisolone in bilateral simultaneous optic neuritis.
    Panagariya A; Sureka RK; Singh R; Chaturvedi M
    J Assoc Physicians India; 1999 Aug; 47(8):798-800. PubMed ID: 10778626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversibility of acute demyelinating lesions in relapsing-remitting multiple sclerosis.
    Khan OA; Rothman MI
    J Pak Med Assoc; 2000 Apr; 50(4):128-30. PubMed ID: 10851834
    [No Abstract]   [Full Text] [Related]  

  • 34. Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response.
    Evangelopoulos ME; Nasiri-Ansari N; Kassi E; Papadopoulou A; Evangelopoulos DS; Moutsatsou P
    Sci Rep; 2021 Sep; 11(1):19462. PubMed ID: 34593869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [2012: Update on diagnosis and treatment of multiple sclerosis].
    Havla J; Kümpfel T; Hohlfeld R
    Dtsch Med Wochenschr; 2012 Apr; 137(17):894-9. PubMed ID: 22492476
    [No Abstract]   [Full Text] [Related]  

  • 36. Reversible impaired memory induced by pulsed methylprednisolone in patients with MS.
    Uttner I; Müller S; Zinser C; Maier M; Süssmuth S; Claus A; Ostermann B; Elitok E; Ecker D; Brettschneider J; Gold R; Tumani H
    Neurology; 2005 Jun; 64(11):1971-3. PubMed ID: 15955958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Panuveitis associated with multiple sclerosis complicated by cerebral venous thrombosis.
    Kadayifçilar S; Gedik S; Eldem B; Balaban H; Kansu T
    Ocul Immunol Inflamm; 2004 Jun; 12(2):153-7. PubMed ID: 15512986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of oral and intravenous methylprednisolone treatment on subsequent relapse rate in multiple sclerosis.
    Sharrack B; Hughes RA; Morris RW; Soudain S; Wade-Jones O; Barnes D; Brown P; Britton T; Francis DA; Perkin GD; Rudge P; Swash M; Katifi HA; Farmer S; Frankel JP
    J Neurol Sci; 2000 Feb; 173(1):73-7. PubMed ID: 10675582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptomatic, steroid-induced, multifocal diaphyseal osteonecrosis in a patient with multiple sclerosis.
    Sinclair V; Shepard G
    Mult Scler; 2010 Mar; 16(3):370-2. PubMed ID: 20086027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of methylprednisolone on emotional functioning of patients with multiple sclerosis].
    Kułakowska A; Drozdowski W; Halicka D; Kochanowicz J; Braszko JJ
    Pol Merkur Lekarski; 2002 Sep; 13(75):200-3. PubMed ID: 12474570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.